Never Too Late to Quit Smoking: New Research Highlights Positive Treatment Outcomes in Head & Neck Patients - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Never Too Late to Quit Smoking: New Research Highlights Positive Treatment Outcomes in Head & Neck Patients

Dr. Anurag Singh and team note survival rates across non-smokers, smokers and those who recently quit.

  • January 9, 2023

Share

Clinical Scorecard: Never Too Late to Quit Smoking: New Research Highlights Positive Treatment Outcomes in Head & Neck Patients

At a Glance

CategoryDetail
ConditionHead and Neck Cancer
Key MechanismsImpact of smoking on treatment efficacy and survival rates.
Target PopulationPatients diagnosed with head and neck cancers, particularly smokers.
Care SettingOncology, specifically at Roswell Park Comprehensive Cancer Center.

Key Highlights

  • Current smokers who quit prior to treatment saw a 20% improvement in long-term survival.
  • Former smokers had similar outcomes to never smokers, even if they had just quit.
  • 22 pack years of smoking is a critical threshold for estimating treatment outcomes.

Guideline-Based Recommendations

Diagnosis

  • Assess smoking history and HPV status to stratify risk.

Management

  • Encourage smoking cessation services for current smokers before treatment.

Monitoring & Follow-up

  • Track smoking status and pack years to evaluate treatment outcomes.

Risks

  • Current smoking can negate the benefits of HPV-associated tumors and affect survival.

Patient & Prescribing Data

Patients with head and neck cancers, both current and former smokers.

Cessation prior to treatment can significantly improve survival rates.

Clinical Best Practices

  • Delay initiation of therapy to allow for smoking cessation.
  • Utilize cessation services for all patients with smoking-related tumors.

Related Resources & Content

Original Source(s)

Never Too Late to Quit Smoking: New Research Highlights Positive Treatment Outcomes in Head & Neck Patients

  • January 9, 2023

Related Content

The Prognostic Role of Fusobacterium nucleatum in Head and Neck Cancers: A Meta-Analysis of Key Oncological Outcomes

Utilizing ChatGPT for Assessing Dysphagia in Patients Undergoing Radiotherapy for Head and Neck Cancer: An Effective Tool

Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will share the findings of a novel approach using radiation therapy to treat lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 27-Oct. 1, 2025, in San Francisco.

  • September 23, 2025

  • 3 min